SET7/9 (human recombinant)

Stability : 6 months
Formulation :
50 mM sodium phosphate, pH 7.2, containing 100 mM sodium chloride and 20% glycerol
Description : 
SET7/9 methylates histone H3, tumor suppressor p53, and transcription factor TAF10. Recently, SET7/9 was shown to catalyze methylation of p53 in response to DNA damage thereby activating p53 for subsequent acetylation. SET7/9 is able to modulate p53 activity in a human cancer cell line, implying that it may play a significant role in human tumorigenesis.
Purity : >95%
Storage:-80°C